glp 1 and ibd OBESITY by @EdwardLoftus2 Obesity is a chronic inflammatory statue Adipose tissue is not biologically inert (TNFa, IL-6, IL-8, leptin, adiponectin) Postulated role in the pathogenesis of IBD Potential risk factor Treating Obesity in IBD With

MegaFood offers a comprehensive range of probiotic and prebiotic supplements designed to support different aspects of digestive and gut health

And it helps maintain satiety between meals, working with rather than against the GLP-1 medication mechanism

International Journal of Obesity 31 : 743 4

These medications are well researched, and the majority of patients tolerate them well when treatment is introduced gradually and monitored closely

Side Effects and the Usual Timeline Most people notice the strongest side effects: in the first 2 to 6 weeks after each dose increase after very large or high-fat meals For many, symptoms slowly soften